About Rmmedi Innovations
Rmmedi Innovations is a company based in Kottayam (India) founded in 2018 by Stephen George, Digo Joseph Sebastian, and Joseph Thomas. It operates as a B2B. Rmmedi Innovations operates in a competitive market with competitors including Adhezion Biomedical, Inno Therapy, HyperBranch Medical, BRIJ Medical and Suturegard, among others.
- Headquarter Kottayam, India
- Founders Stephen George, Digo Joseph Sebastian, Joseph Thomas
- SectorsHealthcare
- Website rmmedi.com
- Legal Name Rmmedi Innovations Private Limited
- Date of Incorporation 04 Oct, 2018
- Jurisdiction Kottayam, Kerala, India
- Annual Revenue₹12 Lakh
FY 2023 · -67% YoY
- Net Loss-₹11.9 Lakh
FY 2023 · -99% margin
- EBITDA-₹11 Lakh
FY 2023 · -92% margin
Associated legal entities of Rmmedi Innovations
Rmmedi Innovations operates through Rmmedi Innovations Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Rmmedi Innovations Private Limited CIN U33100KL2018PTC055000 | Active | 04 Oct 2018 | Kottayam, Kerala | ₹0.1 Cr | – | 2 | View details |
Board of directors of Rmmedi Innovations Private Limited (Rmmedi Innovations)
Rmmedi Innovations Private Limited is the primary company behind Rmmedi Innovations. The board of Rmmedi Innovations Private Limited currently have 2 directors; the longest-serving is Stephen George, appointed in 2018. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Stephen George DIN 08249078 | Managing Director | 04 Oct 2018 | 8 yrs | Rmmedi Innovations Private Limited |
| Joseph Thomas DIN 08315842 | Director | 03 Jan 2019 | 7 yrs 9 mo | Rmmedi Innovations Private Limited |
People of Rmmedi Innovations
3 people are tracked at Rmmedi Innovations (3 in leadership).
| Name | Role | Group |
|---|---|---|
| Co-Founder, Managing Director | Leadership | |
| Co-Founder, CEO | Leadership | |
| Co-Founder, Director | Leadership |
Complete people profiles for Rmmedi Innovations
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Rmmedi Innovations
Figures of Rmmedi Innovations Private Limited, the primary company behind Rmmedi Innovations, for FY 2023. Revenue was ₹12 Lakh (-67% year on year). Net loss was -₹11.9 Lakh (-99% margin). EBITDA was -₹11 Lakh (-92% margin). Revenue has grown at a compounded annual rate of -14% over three years.
- ₹12 LakhRevenue · FY 2023 · -67% YoY
- -₹11.9 LakhNet loss · -99% margin
- -₹11 LakhEBITDA · -92% margin
- ₹49 LakhPaid-up capital
- -14%Revenue CAGR, 3 years
Balance sheet, profit and loss, cash flow and ratios of Rmmedi Innovations Private Limited are on its company page.
Detailed financial statements for Rmmedi Innovations
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Competitors of Rmmedi Innovations
Rmmedi Innovations operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Adhezion Biomedical, Inno Therapy, HyperBranch Medical, BRIJ Medical and Suturegard, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| adhezion.com | 2001 | Wyomissing, United States | $10.14M | 39 | Developer of cyanoacrylate based surgical, wound management, and infection prevention products | |
| innotherapy.com | 2010 | Seoul, South Korea | $2.77M | – | Hemostatic polymers are produced for surgical and wound care applications. | |
| hyperbranch.com | 2003 | Durham, United States | $18.69M | – | Biosurgical devices are developed using proprietary polymers and hydrogels. | |
| brijmedical.com | 2016 | Marietta, United States | $6.78M | – | Medical devices for post-surgical and trauma incision care are provided. | |
| suturegard.com | 2015 | Portland, United States | $580,000 | – | Wound closure devices for skin are manufactured by Suturegard. | |
| musselpolymers.com | 2019 | Bethlehem, United States | $500,000 | – | Adhesive solutions are manufactured for diverse materials and applications. | |
| purenum.com | 2017 | Bremen, Germany | – | – | Biocompatible adhesives for kidney stone fragment removal are developed. | |
| nvirovate.com | 2021 | Seattle, United States | $750,000 | – | Provider of bio adhesives from soy oil | |
| borayer.com | 2020 | Nanchang, China | – | – | Biomaterials for surgery and wound repair are developed. | |
| limaxbiosciences.com | 2021 | Boston, United States | – | – | Stretchable hydrogel adhesives are developed for wound sealing and healing. |
Detailed competitors of Rmmedi Innovations
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Similar companies to Rmmedi Innovations
10 companies that operate in the same segment as Rmmedi Innovations (Wound Care), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanotech-based wound care products are developed and provided. | 2010 | Madison, Wisconsin, United States | USD 22.7 M | – | 35 | |
Fish-skin acellular dermal matrix technology is provided for wound treatments. | 2007 | Isafjordur, Iceland | USD 93.11 M | – | 150 | |
Developer of advanced haemostat and wound care dressing products | 2008 | Ahmedabad, Gujarat, India | USD 42.71 M | USD 2.88 M | 70 | |
Oxygen-based wound therapy devices are developed for healing non-healing wounds. | 2003 | Waterbeach, Cambridgeshire, United Kingdom | USD 68.39 M | – | – | |
Regenerative biomaterial products and bioimplants for wound, surgical, sports medicine and orthopedics | 1985 | Marietta, Georgia, United States | – | USD 418.63 M | 837 | |
Biological drugs for skin and mucosa wound treatment are developed. | 2016 | Uppsala, Uppsala County, Sweden | USD 4.02 M | USD 1.12 M | – | |
Developer of hemostatic products for wound care | 2010 | New York, New York, United States | USD 113.35 M | – | – | |
Regenerative therapies for wound care are developed and commercialized. | 1985 | Canton, Ohio, United States | USD 30 M | USD 564.17 M | 869 | |
Cold plasma solutions for wound treatment are developed. | 2013 | Eindhoven, Noord-brabant, Netherlands | USD 7.06 M | – | – | |
Point-of-care devices for wound bacterial assessment are provided. | 2013 | Toronto, Ontario, Canada | USD 43.2 M | – | 49 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Rmmedi Innovations
Rmmedi Innovations was founded in 2018.
Rmmedi Innovations is headquartered in Kottayam, India. It is registered at Kottayam, Kerala, India.
Digo Joseph Sebastian is the current CEO of Rmmedi Innovations. They have also founded this company.
The primary company behind Rmmedi Innovations, Rmmedi Innovations Private Limited, reported revenue of ₹12 Lakh for FY 2023, down 67% year on year.
Rmmedi Innovations, led by Stephen George as Co-Founder, Managing Director, Digo Joseph Sebastian as Co-Founder, CEO, Joseph Thomas as Co-Founder, Director, specializes in providing healthcare solutions, developing medical devices, wound care, and technology innovations. Develops innovative technologies for advanced wound care systems. The team drives innovation, quality service, and sustainable practices to achieve excellence and client satisfaction.
Rmmedi Innovations's top competitors include Adhezion Biomedical, BRIJ Medical and Inno Therapy.
Rmmedi Innovations operates through Rmmedi Innovations Private Limited.
The legal entities of Rmmedi Innovations currently have 2 directors, including Joseph Thomas, Stephen George.